These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

406 related items for PubMed ID: 26036454

  • 1. DHEAS and cortisol/DHEAS-ratio in recurrent depression: State, or trait predicting 10-year recurrence?
    Mocking RJ, Pellikaan CM, Lok A, Assies J, Ruhé HG, Koeter MW, Visser I, Bockting CL, Olff M, Schene AH.
    Psychoneuroendocrinology; 2015 Sep; 59():91-101. PubMed ID: 26036454
    [Abstract] [Full Text] [Related]

  • 2. Longitudinal hypothalamic-pituitary-adrenal axis trait and state effects in recurrent depression.
    Lok A, Mocking RJ, Ruhé HG, Visser I, Koeter MW, Assies J, Bockting CL, Olff M, Schene AH.
    Psychoneuroendocrinology; 2012 Jul; 37(7):892-902. PubMed ID: 22094110
    [Abstract] [Full Text] [Related]

  • 3. Cortisol, dehydroepiandrosterone sulfate, fatty acids, and their relation in recurrent depression.
    Ter Horst DM, Schene AH, Figueroa CA, Assies J, Lok A, Bockting CLH, Ruhé HG, Mocking RJT.
    Psychoneuroendocrinology; 2019 Feb; 100():203-212. PubMed ID: 30388594
    [Abstract] [Full Text] [Related]

  • 4. Fatty acid metabolism and its longitudinal relationship with the hypothalamic-pituitary-adrenal axis in major depression: Associations with prospective antidepressant response.
    Mocking RJ, Verburg HF, Westerink AM, Assies J, Vaz FM, Koeter MW, Ruhé HG, Schene AH.
    Psychoneuroendocrinology; 2015 Sep; 59():1-13. PubMed ID: 26010860
    [Abstract] [Full Text] [Related]

  • 5. Lower cortisol levels predict recurrence in remitted patients with recurrent depression: a 5.5 year prospective study.
    Bockting CL, Lok A, Visser I, Assies J, Koeter MW, Schene AH, DELTA study group.
    Psychiatry Res; 2012 Dec 30; 200(2-3):281-7. PubMed ID: 22503382
    [Abstract] [Full Text] [Related]

  • 6. Hypothalamic-pituitary-adrenal axis activity and cognition in major depression: The role of remission status.
    Salvat-Pujol N, Labad J, Urretavizcaya M, de Arriba-Arnau A, Segalàs C, Real E, Ferrer A, Crespo JM, Jiménez-Murcia S, Soriano-Mas C, Menchón JM, Soria V.
    Psychoneuroendocrinology; 2017 Feb 30; 76():38-48. PubMed ID: 27883963
    [Abstract] [Full Text] [Related]

  • 7. Hair cortisol as a marker of hypothalamic-pituitary-adrenal Axis activity in female patients with major depressive disorder.
    Pochigaeva K, Druzhkova T, Yakovlev A, Onufriev M, Grishkina M, Chepelev A, Guekht A, Gulyaeva N.
    Metab Brain Dis; 2017 Apr 30; 32(2):577-583. PubMed ID: 28064407
    [Abstract] [Full Text] [Related]

  • 8. Levels and variability of daily life cortisol secretion in major depression.
    Peeters F, Nicolson NA, Berkhof J.
    Psychiatry Res; 2004 Apr 15; 126(1):1-13. PubMed ID: 15081622
    [Abstract] [Full Text] [Related]

  • 9. The predictive value of cortisol levels on 2-year course of depression in older persons.
    Kabia FM, Rhebergen D, van Exel E, Stek ML, Comijs HC.
    Psychoneuroendocrinology; 2016 Jan 15; 63():320-6. PubMed ID: 26546785
    [Abstract] [Full Text] [Related]

  • 10. Increased cortisol awakening response was associated with time to recurrence of major depressive disorder.
    Hardeveld F, Spijker J, Vreeburg SA, Graaf RD, Hendriks SM, Licht CM, Nolen WA, Penninx BW, Beekman AT.
    Psychoneuroendocrinology; 2014 Dec 15; 50():62-71. PubMed ID: 25179322
    [Abstract] [Full Text] [Related]

  • 11. Major depressive disorder and hypothalamic-pituitary-adrenal axis activity: results from a large cohort study.
    Vreeburg SA, Hoogendijk WJ, van Pelt J, Derijk RH, Verhagen JC, van Dyck R, Smit JH, Zitman FG, Penninx BW.
    Arch Gen Psychiatry; 2009 Jun 15; 66(6):617-26. PubMed ID: 19487626
    [Abstract] [Full Text] [Related]

  • 12. Hypothalamic-pituitary-adrenal axis activity in the comorbidity between obsessive-compulsive disorder and major depression.
    Labad J, Soria V, Salvat-Pujol N, Segalàs C, Real E, Urretavizcaya M, de Arriba-Arnau A, Ferrer A, Crespo JM, Jiménez-Murcia S, Soriano-Mas C, Alonso P, Menchón JM.
    Psychoneuroendocrinology; 2018 Jul 15; 93():20-28. PubMed ID: 29684711
    [Abstract] [Full Text] [Related]

  • 13. Cognitive and affective disorders in the elderly: a neuroendocrine study.
    Ferrari E, Mirani M, Barili L, Falvo F, Solerte SB, Cravello L, Pini L, Magri F.
    Arch Gerontol Geriatr Suppl; 2004 Jul 15; (9):171-82. PubMed ID: 15207411
    [Abstract] [Full Text] [Related]

  • 14. Diurnal Hypothalamic-Pituitary-Adrenal Axis Measures and Inflammatory Marker Correlates in Major Depressive Disorder.
    Doolin K, Farrell C, Tozzi L, Harkin A, Frodl T, O'Keane V.
    Int J Mol Sci; 2017 Oct 24; 18(10):. PubMed ID: 29064428
    [Abstract] [Full Text] [Related]

  • 15. [Study of the stress response: role of anxiety, cortisol and DHEAs].
    Boudarene M, Legros JJ, Timsit-Berthier M.
    Encephale; 2002 Oct 24; 28(2):139-46. PubMed ID: 11972140
    [Abstract] [Full Text] [Related]

  • 16. The self-perceived symptom distress and health-related conditions associated with morning to evening diurnal cortisol patterns in outpatients with major depressive disorder.
    Hsiao FH, Yang TT, Ho RT, Jow GM, Ng SM, Chan CL, Lai YM, Chen YT, Wang KC.
    Psychoneuroendocrinology; 2010 May 24; 35(4):503-15. PubMed ID: 19775819
    [Abstract] [Full Text] [Related]

  • 17. Cortisol responses to psychosocial stress predict depression trajectories: social-evaluative threat and prior depressive episodes as moderators.
    Morris MC, Rao U, Garber J.
    J Affect Disord; 2012 Dec 20; 143(1-3):223-30. PubMed ID: 22858210
    [Abstract] [Full Text] [Related]

  • 18. Attenuated DHEA and DHEA-S response to acute psychosocial stress in individuals with depressive disorders.
    Jiang X, Zhong W, An H, Fu M, Chen Y, Zhang Z, Xiao Z.
    J Affect Disord; 2017 Jun 20; 215():118-124. PubMed ID: 28319688
    [Abstract] [Full Text] [Related]

  • 19. Hormonal Dynamics Effect of Serum Insulin-Like Growth Factor I and Cortisol/Dehydroepiandrosterone Sulfate Ratio on Symptom Severity of Major Depressive Disorder.
    Tajiri M, Suzuki Y, Tsuneyama N, Arinami H, Someya T.
    J Clin Psychopharmacol; 2019 Jun 20; 39(4):367-371. PubMed ID: 31211752
    [Abstract] [Full Text] [Related]

  • 20. Salivary alpha-amylase and cortisol responsiveness following electrical stimulation stress in major depressive disorder patients.
    Tanaka Y, Ishitobi Y, Maruyama Y, Kawano A, Ando T, Okamoto S, Kanehisa M, Higuma H, Ninomiya T, Tsuru J, Hanada H, Kodama K, Isogawa K, Akiyoshi J.
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Mar 30; 36(2):220-4. PubMed ID: 22063648
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.